OPHTHALMIC DIVISION / EYE DROPS | |||||
S.NO. | PRODUCT NAME | COMPOSITION | PACK | ||
1 | BETA - N EYE/EAR DROPS | Sodium Carboxyl Methyl Cellulose | 5ml | ||
2 | BACTIQUINE EYE/EAR DROPS | Ciprofloxacin 0.3% and HPMC | 5ml | ||
3 | CEDEX EYE/EAR DROPS | Chloramphenicol 1.0%, Dexamethasone 0.1% | 5ml | ||
4 | CYCLIN EYE DROPS | Cyclopentolate1% | 5ml | ||
5 | FLUROM EYE DROP | Fluorometholone 0.1% w/v | 5ml | ||
6 | GATICON EYE DROP | Gatifloxacin 0.3% | 5ml | ||
7 | KEROL EYE DROPS | Ketorolac Tromethamine 0.4% | 5ml | ||
8 | LETNOL EYE DROP | Latanoprost 0.005% | 2.5ml | ||
9 | LEVOFIN EYE DROP | Levofloxacin 1.5% | 5ml | ||
10 | LOM-D EYE DROPS | Lomefloxacin 0.3%, Dexamethasone 0.1% | 5ml | ||
11 | M-FLOXIN EYE DROP | Moxifloxacin 0.5% w/v | 5ml | ||
12 | MOX - MOX EYE DROP | Moxifloxacin 0.5% w/v | 5ml | ||
13 | M-FLOXIN - K EYE DROP | Moxifloxacin 0.5%, Ketorolac 0.5% | 5ml | ||
14 | M-FLOXIN - P EYE DROP | Moxifloxacin 0.5%, Predinisolone 1% | 5ml | ||
15 | NAPHAZOLE - C EYE DROPS | Naphazoline .056%, CPM .01%, ZnSO4 .12%, Boric Acid 1.25%, Sodium Chloride | 10ml | ||
16 | NOTIN EYE DROP | Nepafenac 0.1% | 5ml | ||
17 | OFIN EYE DROPS | Ofloxacin 0.3% | 5ml | ||
18 | OFIND EYE DROPS | Ofloxacin 0.3%, Dexamethasone 0.1% | 5ml | ||
19 | OFIN – P EYE DROPS | Ofloxacin 0.3%, Predinisolone 0.1% | 5ml | ||
20 | OCUDEX EYE DROPS | Ciprofloxacin 0.03%, Dexamethasone 0.1% | 5ml | ||
21 | OPTID EYE DROPS | KI 3.3%, NaCl 0.83%, CaCl 1% | 10ml | ||
22 | OSCOCIP-D EYE DROP | Ciprofloxacin 0.03% , Dexamethasone 0.1% | 10ml | ||
23 | OSCOFIN-D EYE DROP | Ofloxacin 0.3% Dexamethasone 0.1% | 10ml | ||
24 | OSCOPET EYE DROP | Olopatadine HCL 0.1% | 5ml | ||
25 | SCARMIDE – C EYE DROPS | Sulphacetamide 20%, Chloramphenicol 10.5% | 5ml | ||
26 | TMC EYE DROPS | Tobramycin 0.3% | 5ml | ||
27 | TMC-B EYE DROPS | Tobramycin 0.3%, Betamethasone 0.1% | 5ml | ||
28 | TMC-F EYE DROPS | Tobramycin 0.3%, Fluorometholone 0.1% | 5ml | ||
29 | WEL TEARS | Sodium Carboxyl Methyl Cellulose 0.5% | 10ml |
© OSCAR REMEDIES. All Rights Reserved.